LABCORP HOLDINGS INC.·4

Feb 13, 1:11 PM ET

Meltzer Jonathan C 4

Research Summary

AI-generated summary

Updated

Labcorp (LH) EVP Jonathan Meltzer Converts RSUs, Sells 157 Shares

What Happened
Jonathan C. Meltzer, Executive Vice President, Operations at Labcorp (LH), had 243 Restricted Stock Units (RSUs vest) on Feb 11, 2026 and converted them into 243 shares. Of those, 70 shares were withheld to satisfy tax withholding (70 @ $289.89 = $20,292) and 87 shares were sold in the open market (87 @ $290.42 = $25,267) under a prearranged plan. The total proceeds from the sales/withholding events equal about $45,559. These were not purchases (no bullish buy); they reflect vesting and routine tax withholding and sales.

Key Details

  • Transaction dates: RSU conversion/vesting on 2026-02-11; open-market sale on 2026-02-12; Form filed 2026-02-13 (appears timely).
  • Prices/values: tax-withhold 70 shares @ $289.89 = $20,292; open-market sale 87 shares @ $290.42 = $25,267.
  • Shares retained from this vesting: 243 vested − 70 withheld − 87 sold = 86 shares retained. Total holdings after the filing are not specified in the Form 4.
  • Footnotes: RSUs convert 1-for-1 to common shares (F1). 70-share transaction is stock withholding for taxes (F2). The open-market sale was executed pursuant to a Rule 10b5‑1 plan (F3). The vested RSUs are from a grant that vests in three equal annual installments starting Feb 11, 2026 (F4). F5 notes the reported RSU aggregate number.

Context

  • These entries reflect a vesting/conversion of RSUs (a derivative-to-share event) followed by routine tax withholding and a sale, not a fresh cash purchase. The sequence (vest → tax-withhold → partial sale under a 10b5‑1 plan) is a common cashless/settlement pattern for RSU awards.
  • Because the sale was made under a prearranged 10b5‑1 plan, timing is likely predetermined and not an ad hoc trade decision.